Heidelberg Pharma AG(DE:HPHA)
€2.12-0.05 (-2.30%)
DE:HPHA
Heidelberg Pharma AG financials statements
€2.12
At close:-0.05 (-2.30%)
Want to see DE:HPHA full AI Analyst Report?
Heidelberg Pharma AG (HPHA) Financial Statements
5 Followers
Heidelberg Pharma AG Financial Overview
Heidelberg Pharma AG's market cap is currently €101.52M. The company's EPS TTM is €-0.64; its P/E ratio is -3.39; Heidelberg Pharma AG has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Feb 26 | Feb 25 | Feb 24 | Feb 23 | Feb 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € 1.46M | € 6.85M | € 9.86M | € 18.51M | € 2.90M |
| Gross Profit | € -1.19M | € 5.07M | € 6.61M | € 13.83M | € -1.81M |
| Operating Income | € -47.44M | € -20.67M | € -21.21M | € -17.18M | € -25.14M |
| EBITDA | € -44.63M | € -14.48M | € -18.71M | € -16.19M | € -24.35M |
| Net Income | € -42.28M | € -19.38M | € -20.35M | € -19.70M | € -26.14M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | € 14.98M | € 29.42M | € 43.44M | € 81.33M | € 6.14M |
| Total Assets | € 38.14M | € 60.72M | € 70.35M | € 100.58M | € 21.73M |
| Total Debt | € 1.16M | € 21.97M | € 5.83M | € 15.98M | € 10.63M |
| Net Debt | € -13.81M | € -7.45M | € -37.61M | € -65.35M | € 4.49M |
| Total Liabilities | € 49.05M | € 29.85M | € 21.01M | € 33.94M | € 15.03M |
| Stockholders' Equity | € -10.92M | € 30.87M | € 49.34M | € 66.64M | € 6.70M |
| Cash Flow | |||||
| Free Cash Flow | € -31.73M | € -30.04M | € -34.63M | € -9.48M | € -28.00M |
| Operating Cash Flow | € -31.60M | € -29.59M | € -33.67M | € -8.86M | € -26.61M |
| Investing Cash Flow | € -135.05K | € -449.13K | € 5.85M | € -597.57K | € -1.40M |
| Financing Cash Flow | € 18.35M | € 16.08M | € -10.05M | € 84.00M | € 29.17M |
Currency in EUR
